Variable expression of osteogenesis imperfecta in a nuclear family is explained by somatic mosaicism for a lethal point mutation in the alpha 1(I) gene (COL1A1) of type I collagen in a parent.

作者: B J Starman , P H Byers , G A Wallis , A B Zinn

DOI:

关键词:

摘要: Fibroblasts from a man with mild form of osteogenesis imperfecta (OI) and his son perinatal lethal OI (OI type II) produced normal abnormal I procollagen molecules. The molecules synthesized by both cell strains contained one or two pro alpha 1(I) chains in which the glycine at position 550 triple-helical domain was substituted arginine as result G-to-A transition first base codon. Cells mother only By allele-specific oligonucleotide hybridization to amplified genomic sequences paternal tissues we determined that mutant allele accounted for approximately 50% COL1A1 alleles fibroblasts, 27% those blood, 37% sperm. These findings demonstrate father is mosaic potentially mutation suggest phenotype nature relative abundance different tissues. Furthermore, make it clear some individuals moderate forms are mutations will be their offspring.

参考文章(16)
Hall Jg, Review and hypotheses: somatic mosaicism: observations related to clinical genetics. American Journal of Human Genetics. ,vol. 43, pp. 355- 363 ,(1988)
B J Starman, P H Byers, R C Schwartz, P Tsipouras, J F Bonadio, Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen. American Journal of Human Genetics. ,vol. 42, pp. 237- 248 ,(1988)
R E Gelinas, J Jacob, P H Byers, J Bonadio, K A Holbrook, Altered triple helical structure of type I procollagen in lethal perinatal osteogenesis imperfecta. Journal of Biological Chemistry. ,vol. 260, pp. 1734- 1742 ,(1985) , 10.1016/S0021-9258(18)89655-7
J F Bateman, D Chan, I D Walker, J G Rogers, W G Cole, Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen. Journal of Biological Chemistry. ,vol. 262, pp. 7021- 7027 ,(1987) , 10.1016/S0021-9258(18)48196-3
B J Starman, D Eyre, H Charbonneau, M Harrylock, M A Weis, L Weiss, J M Graham, P H Byers, Osteogenesis imperfecta. The position of substitution for glycine by cysteine in the triple helical domain of the pro alpha 1(I) chains of type I collagen determines the clinical phenotype. Journal of Clinical Investigation. ,vol. 84, pp. 1206- 1214 ,(1989) , 10.1172/JCI114286
PETER H. BYERS, JEFFREY F. BONADIO, DANIEL H. COHN, BARBRA J. STARMAN, RICHARD J. WENSTRUP, MARCIA C. WILLING, Osteogenesis imperfecta: the molecular basis of clinical heterogeneity. Annals of the New York Academy of Sciences. ,vol. 543, pp. 117- 128 ,(1988) , 10.1111/J.1749-6632.1988.TB55324.X
R. Saiki, D. Gelfand, S Stoffel, S. Scharf, R Higuchi, G. Horn, K. Mullis, H. Erlich, Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase Science. ,vol. 239, pp. 487- 491 ,(1988) , 10.1126/SCIENCE.2448875
Joachim Messing, Roberto Crea, Peter H. Seeburg, A system for shotgun DNA sequencing. Nucleic Acids Research. ,vol. 9, pp. 309- 321 ,(1981) , 10.1093/NAR/9.2.309